Skip to content
Independent analysis of NHS open data
PharmaInsight

Sarilumab

Musculoskeletal and Joint Diseases Drugs used in rheumatic diseases and gout BNF 1001030AD
Data updated October 2024 Download CSV
1items

Dispensed in October 2024

0items

Rolling 12 months

£912

Net ingredient cost · October 2024

Figure 1. Sarilumab: national items dispensed by month

0 0.5 1 Nov 2021 Dec 2021 Jan 2022 Feb 2022 Oct 2024 1 Nov 2021: 1 Dec 2021: 1 Jan 2022: 1 Feb 2022: 1 Oct 2024: 1

Source: NHSBSA Prescription Cost Analysis, to October 2024

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs used in rheumatic diseases and gout
  • Presentations 1 shown
  • Average cost / item £912.25
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, October 2024

The individual products dispensed under Sarilumab this month.

Presentations of Sarilumab, October 2024
Presentation BNF code Items Net ingredient cost
Kevzara 150mg/1.14ml solution for injection pre-filled pens 1001030ADBBACAC 1 £912

Source: NHSBSA Prescription Cost Analysis · to October 2024 OGL v3.0

Where Sarilumab is dispensed

The regions and dispensing practices with the highest Sarilumab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Sarilumab with

Other medicines in the same BNF section, by prescribing volume.